Risk-Based Screening Mammography for Women Aged <40: Outcomes From the National Mammography Database.


Journal

Journal of the American College of Radiology : JACR
ISSN: 1558-349X
Titre abrégé: J Am Coll Radiol
Pays: United States
ID NLM: 101190326

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 27 06 2019
revised: 16 08 2019
accepted: 25 08 2019
pubmed: 22 9 2019
medline: 22 6 2021
entrez: 22 9 2019
Statut: ppublish

Résumé

There is insufficient large-scale evidence for screening mammography in women <40 years at elevated risk. This study compares risk-based screening of women aged 30 to 39 with risk factors versus women aged 40 to 49 without risk factors in the National Mammography Database (NMD). This retrospective, HIPAA-compliant, institutional review board-exempt study analyzed data from 150 NMD mammography facilities in 31 states. Patients were stratified by 5-year age intervals, availability of prior mammograms, and specific risk factors for breast cancer: family history of breast cancer, personal history of breast cancer, and dense breasts. Four screening performance metrics were calculated for each age and risk group: recall rate (RR), cancer detection rate (CDR), and positive predictive values for biopsy recommended (PPV Data from 5,986,131 screening mammograms performed between January 2008 and December 2015 in 2,647,315 women were evaluated. Overall, mean CDR was 3.69 of 1,000 (95% confidence interval: 3.64-3.74), RR was 9.89% (9.87%-9.92%), PPV Women with one or more of these three specific risk factors likely benefit from screening commencing at age 30 instead of age 40.

Identifiants

pubmed: 31541655
pii: S1546-1440(19)31034-8
doi: 10.1016/j.jacr.2019.08.033
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

368-376

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Auteurs

Cindy S Lee (CS)

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California; Department of Radiology, New York University Langone Health, Garden City, New York. Electronic address: Cindy.Lee3@nyumc.org.

Heidi Ashih (H)

Center for Research and Innovation, ACR, Reston, Virginia.

Debapriya Sengupta (D)

Department of Quality and Safety, ACR, Reston, Virginia.

Edward A Sickles (EA)

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.

Margarita Zuley (M)

Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Etta Pisano (E)

Center for Research and Innovation, ACR, Reston, Virginia; Department of Radiology, Beth Israel Deaconess Medical Center, Cambridge, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH